These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1549367

  • 1. Protein complexes bearing myc-like antigenicity recognize two distinct DNA sequences.
    Negishi Y, Iguchi-Ariga SM, Ariga H.
    Oncogene; 1992 Mar; 7(3):543-8. PubMed ID: 1549367
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG, Bahram F, Burkhardt H, Lüscher B.
    Oncogene; 1997 Aug 07; 15(6):737-48. PubMed ID: 9264414
    [Abstract] [Full Text] [Related]

  • 3. DNA binding by N- and L-Myc proteins.
    Ma A, Moroy T, Collum R, Weintraub H, Alt FW, Blackwell TK.
    Oncogene; 1993 Apr 07; 8(4):1093-8. PubMed ID: 8455937
    [Abstract] [Full Text] [Related]

  • 4. Identification and cDNA cloning of single-stranded DNA binding proteins that interact with the region upstream of the human c-myc gene.
    Negishi Y, Nishita Y, Saëgusa Y, Kakizaki I, Galli I, Kihara F, Tamai K, Miyajima N, Iguchi-Ariga SM, Ariga H.
    Oncogene; 1994 Apr 07; 9(4):1133-43. PubMed ID: 8134115
    [Abstract] [Full Text] [Related]

  • 5. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
    Buckle RS, Méchali M.
    Oncogene; 1995 Mar 16; 10(6):1249-55. PubMed ID: 7700652
    [Abstract] [Full Text] [Related]

  • 6. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J, Lüscher B.
    Biol Chem; 1999 Sep 16; 380(9):1121-6. PubMed ID: 10543451
    [Abstract] [Full Text] [Related]

  • 7. Max and c-Myc/Max DNA-binding activities in cell extracts.
    Littlewood TD, Amati B, Land H, Evan GI.
    Oncogene; 1992 Sep 16; 7(9):1783-92. PubMed ID: 1501888
    [Abstract] [Full Text] [Related]

  • 8. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA.
    Oncogene; 1993 Jul 16; 8(7):1849-55. PubMed ID: 8510929
    [Abstract] [Full Text] [Related]

  • 9. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K, Henriksson M, Lüscher-Firzlaff JM, Litchfield DW, Lüscher B.
    Oncogene; 1993 Dec 16; 8(12):3211-20. PubMed ID: 8247525
    [Abstract] [Full Text] [Related]

  • 10. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I, Mäkelä TP, Koskinen PJ, Alitalo K.
    Oncogene; 1995 Aug 03; 11(3):553-60. PubMed ID: 7630640
    [Abstract] [Full Text] [Related]

  • 11. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S.
    Cancer Res; 1998 Aug 15; 58(16):3654-9. PubMed ID: 9721875
    [Abstract] [Full Text] [Related]

  • 13. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors.
    Berberich S, Hyde-DeRuyscher N, Espenshade P, Cole M.
    Oncogene; 1992 Apr 15; 7(4):775-9. PubMed ID: 1565473
    [Abstract] [Full Text] [Related]

  • 14. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B.
    Oncogene; 1995 Aug 03; 11(3):587-96. PubMed ID: 7630643
    [Abstract] [Full Text] [Related]

  • 15. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 16. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I, Mäkelä TP, Koskinen PJ, Saksela K, Alitalo K.
    Princess Takamatsu Symp; 1991 May 13; 22():307-18. PubMed ID: 1668890
    [Abstract] [Full Text] [Related]

  • 17. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
    Kime L, Wright SC.
    Biochem J; 2003 Feb 15; 370(Pt 1):291-8. PubMed ID: 12418961
    [Abstract] [Full Text] [Related]

  • 18. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V, Leff T, Saltiel AR.
    Mol Cell Neurosci; 1994 Jun 15; 5(3):277-82. PubMed ID: 8087425
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A, Abril-Marti M, Illi B, Cesareni G, Nasi S.
    J Mol Biol; 1995 May 05; 248(3):541-50. PubMed ID: 7752223
    [Abstract] [Full Text] [Related]

  • 20. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.